Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

21.07.17	Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis (GlobeNewswire)
14.07.17	Emergent BioSolutions To Buy ACAM2000 Business From Sanofi For Up To $125 Mln (RTTNews)
12.07.17	Sanofi: Availability of the Pre-quarterly Results Communication (GlobeNewswire)
12.07.17	ORMP To Meet With FDA, Second Time's No Charm For OCUL, Panel Backs PFE (RTTNews)
11.07.17	Sanofi To Buy Protein Sciences (RTTNews)
10.07.17	Sanofi Genzyme Reports Results From Phase 2 Open-Label Extension Study (RTTNews)
07.07.17	Alnylam, Sanofi Initiate ATLAS Phase 3 Program With RNAi Therapeutic Fitusiran (RTTNews)
27.06.17	Sanofi Announces Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA) in the European Union (PR Newswire)
27.06.17	Sanofi Announces Licensing of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA) in the European Union (PR Newswire)
27.06.17	Regeneron: EC Okays Kevzara To Treat Moderately To Severely Active RA (RTTNews)
15.06.17	Start Your Morning With a Cup of Coffee and an Ounce of Dengue Prevention (PR Newswire)
12.06.17	LXRX Brings Sweet Tidings, PFE's PROSPER Ahead Of Schedule, XBIT Fails To Excite (RTTNews)
12.06.17	Sanofi Announces Results From Two Phase 3b/4 ODYSSEY-DM Trials In Diabetes (RTTNews)
04.06.17	Regeneron, Sanofi Present Positive Study Results For PD-1 Antibody REGN2810 (RTTNews)
30.04.17	Monday Is D-Day For AEZS, Watch Out For MRUS, FDA Nod For RDUS & Takeda (RTTNews)
28.04.17	Sanofi Stock Up As Q1 Profit Surges On Merial Disposal; Backs FY17 View (RTTNews)
28.04.17	Sanofi Q1 Profit Soars On Merial Disposal, Higher Sales; Backs FY17 View (RTTNews)
28.04.17	Sanofi: FDA Sets New Action Date For Kevzara BLA As May 22, 2017 - Quick Facts (RTTNews)
26.04.17	AKBA Jumps On Otsuka Deal, MNOV Abuzz, CAPR Counting On HOPE... (RTTNews)
25.04.17	D-Day For CAPR Today, OMED Hands Out Pink Slips, JAZZ Hits Right Notes... (RTTNews)
24.04.17	Sanofi Sues Mylan Over EpiPen Marketing (RTTNews)
24.04.17	Sanofi:FDA Oks Thymoglobulin For Prevention Of Acute Kidney Transplant Rejection (RTTNews)
24.04.17	Sanofi, Regeneron Say Kevzara Gets CHMP Positive Opinion For RA In Adults (RTTNews)
04.04.17	FDA Nod For TEVA, Cheers For PRTK, SRNE Hits Goal, SNY Launches Kids Toothpaste (RTTNews)
04.04.17	Sanofi-Pasteur Agrees To Pay $19.9 Mln Fine For Drug Overcharges (RTTNews)
29.03.17	First Drug For 2 Forms Of MS Gets FDA Nod, RTTR Abuzz, VRTX Gains On Trial Data (RTTNews)
29.03.17	Regeneron Says FDA Okays New Eczema Drug Dupixent (RTTNews)
27.03.17	VIVUS In Deal To Reacquire STENDRA Commercial Rights From Sanofi - Quick Facts (RTTNews)
21.03.17	Sanofi's Study Says Allergy Sufferer's Sleep To Be Disrupted 4 Times Than Normal (RTTNews)
14.03.17	UK Patients Granted Early Access to Sanofi's Innovative Dermatology Treatment Dupilumab by MHRA (PR Newswire)
14.03.17	UK Patients Granted Early Access to Sanofi's Innovative Dermatology Treatment Dupilumab by MHRA (PR Newswire)
05.03.17	Regeneron, Sanofi: DUPIXENT Study In Atopic Dermatitis Shows Positive Data (RTTNews)
03.03.17	Sanofi Pasteur & AstraZeneca Join To Develop, Commercialize MEDI8897 (RTTNews)
27.02.17	Biotech Stocks Facing FDA Decision In March (RTTNews)
27.02.17	Sanofi, Lonza In Partnership To Build Swiss Biologics Production Facility (RTTNews)
09.02.17	AGTC On Watch, It's Advantage REGN, No Need For FDA Panel Review For Betrixaban (RTTNews)
09.02.17	Sanofi Says Appeals Court Grants Stay Of Permanent Injunction For Praluent (RTTNews)
08.02.17	Sanofi Stock Up As Q4 Profit More Than Doubles (RTTNews)
08.02.17	Sanofi - Interview du Directeur Général - Résultats 2016 (vidéo) (PR Newswire)
08.02.17	Sanofi CEO Interview - FY 2016 Results (video) (PR Newswire)
08.02.17	Sanofi CEO Interview - FY 2016 Results (video) (PR Newswire)
08.02.17	Sanofi Q4 Profit Up; Sees 2017 Business EPS To Be Stable To -3% At CER (RTTNews)
02.02.17	Sanofi's Xyzal Now Available OTC, GLPG Kicks Off ALBATROSS, PRXL Opens Wallet (RTTNews)
01.02.17	Sanofi Appoints Hugo Fry as General Manager UK (PR Newswire)
01.02.17	Regeneron And Sanofi Say Canada Approves Kevzara (RTTNews)
10.01.17	Amgen Issues Statement On Court Decision On Patent Litigation (RTTNews)
06.01.17	OTIC Hits Right Notes, GEMP To Report Data This Month, Busy Year Ahead For RVNC (RTTNews)
06.01.17	Regeneron, Sanofi To Appeal U.S. Court Rulings In Patent Litigation On Praluent (RTTNews)
04.01.17	Sanofi Says Soliqua 100/33 Now Available In U.S. (RTTNews)
02.01.17	Boehringer Ingelheim, Sanofi Successfully Close Business Swap On Jan. 1 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		SPI-Handel aktuell: SPI zum Handelsende leichter
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

SPI-Handel aktuell: SPI zum Handelsende leichter

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Handel in Europa: STOXX 50 schliesst im Minus